glp-1 receptor agonist list Glp 1 Agonists Evolution of GLP‐1 Receptor Agonists

As previously reported, the reduction of inflammation may be related to weight loss, that was significant in the different outcome trials, going from a 0.6-kg reduction at 12 weeks with Lixisenatide in ELIXA trial to 4.3 kg at 2 years with injectable semaglutide in SUSTAIN-6 trial [25, 26]

Double-blind, placebo-controlled pilot trial of L-Leucine-enriched amino-acid mixtures on body composition and physical performance in men and women aged 6575 years

Larsen PJ, Holst JJ

Efficacy and safety of glucagon-like peptide-1 receptor agonists in Parkinsons disease: a systematic review and meta-analysis of randomized placebo-controlled clinical trials

Helping people develop strong social connections may help by reducing stress, increasing motivation and encouraging accountability (Mozafariun et al 2025)